— Know what they know.
/
Not Investment Advice

UHS

NYSE · USD
Universal Health Services, Inc.
Healthcare · Medical - Care Facilities
CEO Marc D. Miller Employees 101,500 R&D / revenue 0.0%
Last price
$185.10−1.21%last session
Market cap
$10.9B
P/E (TTM)
7.5x
From 52w high
−24.9%
From 52w low
+32.1%
1-year return
−9.3%
RSI 14 · vs SMA200
63.5 · +3.7%
IS score
61.1/ 100
Factor model across 8 sub-scores, ranked against 3,010 US stocks. Describes the business, not the outlook.
Download full factsheet (PDF)

One year, rebased to 100

UHS   SPY   XLV (sector ETF) · weekly closes
80100120Jan 26Apr 26Jul 26Oct 26XLV 124SPY 116UHS 91

Score DNA

Each bar is a 0-100 score within the scored universe
60
Profitability
63
Growth
88
Value
86
Momentum
65
Risk (safety)
79
Quality
61
Balance sheet
79
Earnings quality

Flags

Strengths
✓ Piotroski 8+✓ FCF yield 5%+✓ Congress buying
Warnings
None of the computed warning flags fires for UHS (Altman, Beneish, accruals, FCF, dilution).
Observations
Moat model: Narrow, Intangible AssetsPiotroski 8 / 9Altman Z 3.0Beta 1.062 of 4 smart-money sources active

Smart-money strip

Each disclosure source on its own window. Filings coinciding is not coordination.
INSForm 4 · 180 days
Insider open-market buys
0
No open-market sales on file
Form 144 notices (12m): 4, $1.2M proposed, not confirmed sales
CONGSTOCK Act · 180 days
Congressional purchases
1
Last disclosed purchase 2026-03-27
Members disclose in ranges, 30-45 days after the trade
13F13F · quarter to 2026-06-30
Net change in institutional holders
−56
70 new holders, 123 closed
599 filers hold 88.6% · 218 added, 244 trimmed
ETFETF holdings · 30 days
Net funds accumulating
−46
455 funds adding shares
501 funds trimming · counts of funds, not dollars
DARKFINRA · daily
Short-sale share of off-exchange volume
62.8%
20-day avg 74.0%, 50-day avg 69.9%
Latest 11.2 pp under its 20-day average · a flow, not short interest

Key financials · FY2025

USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.
Income statement
Revenue$17.4B
Revenue growth YoY+9.7%
Gross margin90.4%
Operating income$2.0B
Operating margin11.5%
Net income$1.5B
Net margin8.6%
EPS (diluted)$23.10
Cash flow
Operating cash flow$1.9B
Capital expenditure$1.0B
Free cash flow$849.2M
FCF conversion (FCF / OCF)45.6%
Stock-based compensation$95.7M
FCF less SBC$753.6M
Buybacks$968.0M
Dividends$51.3M
Balance sheet & returns
Cash & short-term investments$137.8M
Total debt$5.1B
Net debt$4.9B
Shareholders' equity$7.4B
Goodwill & intangibles$4.1B
Debt / equity0.70
ROE (TTM)20.7%
ROIC (TTM)11.7%
Operating margin by fiscal year
10.8%FY20217.5%FY20228.2%FY202310.6%FY202411.5%FY2025
Revenue $12.6B (FY2021) to $17.4B (FY2025), a 8.3% CAGR.

Valuation

P/E (TTM)7.5x
EV / EBITDA5.7x
Price / sales0.60x
Price / FCF13.2x
FCF yield7.58%
Buyback yield8.87%
SBC / revenue0.3%
Price / book1.47x
Forward P/E FY20268.2x
Forward P/E FY20277.7x
Forward P/E FY20287.1x
Forward multiples divide today's price by Street EPS estimates. Street mean target $196.50 across 8 analysts last quarter is theirs, not ours.

UHS vs industry median

157 companies in Medical - Care Facilities
Gross margin 90.7% 29.6% Operating margin 11.4% 2.4% Net margin 8.4% 1.2% ROIC 11.7% 5.6%
UHS (TTM)Industry median Asset turnover 1.14 vs industry 0.88 · financial leverage 2.12

Earnings delivery

Next report 2026-10-27 · consensus EPS $5.20
92%
beat rate, 11 of 12 quarters
+8.7%
median EPS surprise
9
longest beat streak
+8+9+17+31+2+17+11+9+22-1+6+1
EPS surprise in % vs the consensus at the time, oldest (left) to newest, 2023-10-25 to 2026-07-27. Bars cap at ±60%.

Peers

Market-cap band, not the industry cohort above
CompanyMkt capP/EROENet marginRev growth12m return
UHS Universal Health Services, I $10.9B7.5x20.7%8.4%+9.7% −9.3%
ENSG The Ensign Group, Inc. $10.3B26.9x17.0%6.9%+18.9% −1.6%
DVA DaVita Inc. $12.0B16.1x-149.4%7.5%+6.4% +49.5%
EHC Encompass Health Corporation $12.6B20.6x25.5%9.6%+9.5% +4.0%
PACS PACS Group, Inc. $7.4B27.6x28.1%5.3%+15.2% +276.9%
CHE Chemed Corporation $6.7B25.7x27.1%10.1%+3.3% —
HIMS Hims & Hers Health, Inc. $6.3Bn/m-32.0%-11.5%+28.0% —
THC Tenet Healthcare Corporation $21.5B10.2x53.3%14.7%+5.4% —
12-month window: SPY +15.9%, sector ETF XLV +24.2%. Past returns describe history only.

Recent 8-K filings

2026-08-21Material Agreement; Financial Obligation; Exhibits
2026-08-17Financial Obligation; Other Events; Exhibits
2026-08-13Material Agreement; Exhibits
2026-07-28Earnings Release; Exhibits
2026-07-21Material Agreement; Financial Obligation; Exhibits
2026-05-22Shareholder Vote

Context

Shares outstanding58,936,513
Free float82.8%
Institutional ownership88.6%
Beta1.06
Dividend yield0.43%
Last dividend$0.20 on 2026-09-01
50 / 200-day average$175.05 / $178.70
Large-cap Healthcare median P/E29.7x

Full factsheet

The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Narrow).

Read it in the browser Download (PDF)

All fundamentals · 140 measures in 13 categories

Percentile = where UHS sits among 33 scored companies in Medical - Care Facilities (0 = lowest value, 100 = highest). It is a position, not a grade.
ValuationProfitability (TTM)Returns on capitalGrowthMargin history & stabilityLiquidity (latest quarter)Leverage & solvency (latest quarter)EfficiencyCash flow & earnings qualityDividends & buybacksScores & forensic checksPer shareSize (TTM)

Valuation

MeasureUHSIndustry medianIndustry percentileSector median
P/E (TTM) 7.1x 21.1x
4th		 27.6x
PEG (P/E ÷ 3-yr EPS CAGR) 0.19 0.89
8th		 1.28
Price / sales 0.6x 1.2x
19th		 3.7x
Price / book 1.5x 3.2x
14th		 3.6x
Price / tangible book 2.5x 4.7x
0th		 5.8x
Price / free cash flow 13.2x 15.2x
37th		 21.2x
Price / operating cash flow 6.1x 11.9x
24th		 17.1x
Enterprise value $16.0B $3.6B
91st		 $2.5B
EV / sales 0.9x 1.6x
19th		 3.8x
EV / EBITDA 5.7x 12.3x
7th		 16.2x
EV / EBIT 7.4x 14.6x
7th		 23.0x
EV / free cash flow 19.4x 21.4x
41st		 24.6x
Earnings yield 14.0% 4.0%
97th		 -0.3%
FCF yield 7.6% 5.3%
69th		 1.7%
Operating cash flow yield 16.5% 7.5%
78th		 2.9%
Graham number (per share) $267.97 $17.24
100th		 $26.70

Profitability (TTM)

MeasureUHSIndustry medianIndustry percentileSector median
Gross margin 90.7% 27.8%
100th		 65.1%
EBITDA margin 15.6% 11.3%
69th		 6.6%
Operating margin 11.4% 8.0%
72nd		 3.5%
EBIT margin 12.0% 7.7%
66th		 2.4%
Net margin 8.4% 4.8%
69th		 0.3%
NOPAT margin 8.7% 6.1%
69th		 2.7%
FCF margin 4.6% 6.7%
28th		 4.3%
Operating cash flow margin 9.9% 10.3%
47th		 7.1%
R&D / revenue 0.0% 0.0%
0th		 12.4%
SG&A / revenue 46.7% 15.5%
91st		 37.9%
Stock comp / revenue 0.3% 0.8%
17th		 4.5%
Effective tax rate 23.5% 21.9%
61st		 21.0%

Returns on capital

MeasureUHSIndustry medianIndustry percentileSector median
ROE (on average equity) 21.0% 14.3%
69th		 0.8%
ROA 9.9% 6.2%
78th		 -0.3%
ROIC 12.5% 10.3%
59th		 5.5%
ROCE 17.2% 12.4%
78th		 2.3%
Return on tangible assets 14.1% 10.5%
75th		 1.7%
Cash ROIC (OCF / invested capital) 14.2% 15.0%
44th		 9.7%
Gross profitability (GP / assets) 103.1% 31.1%
97th		 29.9%
ROIC, 3-yr average 9.2% 4.7%
71st		 2.6%
ROIC, 5-yr average 9.5% 7.5%
78th		 3.2%
ROE, 5-yr average 15.5% 7.9%
82nd		 -4.9%
Incremental ROIC 82.7% 76.6%
55th		 17.2%

Growth

MeasureUHSIndustry medianIndustry percentileSector median
Revenue growth (TTM YoY) 10.0% 10.0%
50th		 10.5%
Revenue growth (QoQ) 3.2% 4.0%
34th		 7.2%
Revenue CAGR, 3 yr 9.5% 11.3%
36th		 10.7%
Revenue CAGR, 5 yr 8.2% 10.8%
35th		 12.1%
Gross profit CAGR, 3 yr 10.2% 12.7%
44th		 10.6%
Operating income CAGR, 3 yr 23.4% 12.3%
74th		 11.7%
Net income growth (TTM YoY) 21.0% 21.0%
50th		 17.5%
Net income CAGR, 3 yr 30.2% 23.5%
73rd		 11.3%
EPS growth (TTM YoY) 31.2% 26.0%
56th		 19.2%
EPS CAGR, 3 yr 37.6% 22.5%
80th		 14.0%
EPS CAGR, 5 yr 15.1% 14.1%
57th		 8.1%
FCF growth (TTM YoY) -8.3% 43.8%
15th		 18.6%
FCF CAGR, 3 yr 17.5% 22.1%
41st		 15.4%
Operating cash flow CAGR, 3 yr 15.4% 18.9%
39th		 11.9%
Book value CAGR, 3 yr 13.4% 6.8%
68th		 2.1%
Dividend CAGR, 3 yr 3.6% 2.1%
56th		 2.2%
Sustainable growth rate 20.3% 18.3%
52nd		 12.2%

Margin history & stability

MeasureUHSIndustry medianIndustry percentileSector median
Gross margin, 3-yr average 90.1% 30.0%
100th		 62.6%
Operating margin, 3-yr average 10.7% 6.6%
72nd		 1.0%
Net margin, 3-yr average 7.4% 2.1%
83rd		 -2.6%
FCF margin, 3-yr average 5.2% 5.9%
45th		 3.2%
Revenue stability (0-1) 0.97 0.92
83rd		 0.80
Earnings stability (0-1) 0.45 0.33
72nd		 0.37
Margin stability (0-1) 0.99 0.89
100th		 0.93

Liquidity (latest quarter)

MeasureUHSIndustry medianIndustry percentileSector median
Cash & short-term investments $138.8M $185.6M
31st		 $330.9M
Net cash (− = net debt) −$5.1B −$705.2M
12th		 $8.4M
Working capital $381.7M $116.0M
78th		 $381.1M
Current ratio 1.12 1.27
22nd		 3.02
Quick ratio 1.04 1.23
22nd		 2.51
Cash ratio (cash + ST investments / current liabilities) 0.04 0.39
0th		 1.43
Defensive interval (days) 75 days 420 days
3rd		 415 days

Leverage & solvency (latest quarter)

MeasureUHSIndustry medianIndustry percentileSector median
Total debt $5.3B $1.3B
88th		 $289.1M
Debt / equity 0.70 0.92
36th		 0.45
Net debt / equity 0.68 0.70
46th		 −0.13
Debt / assets 33.0% 37.5%
44th		 24.4%
Debt / capital 41.2% 48.0%
36th		 31.1%
Debt / EBITDA 1.87 2.71
29th		 2.62
Net debt / EBITDA 1.82 2.19
39th		 1.42
Interest coverage (EBIT / interest) 13.9x 5.6x
70th		 2.1x
Cash interest coverage 11.5x 9.7x
57th		 3.6x
Debt payback (years of OCF) 2.9 yrs 3.7 yrs
41st		 2.7 yrs
Liabilities / assets 52.0% 61.0%
34th		 49.8%
IS credit model rating A — —
Implied credit spread (bps) 150 225
31st		 225

Efficiency

MeasureUHSIndustry medianIndustry percentileSector median
Asset turnover 1.17 1.03
56th		 0.56
Fixed asset turnover 2.41 3.59
23rd		 4.87
Inventory turnover 7.4 35.3
0th		 2.7
Receivables turnover 7.1 8.8
19th		 6.4
Days sales outstanding 51 days 41 days
81st		 57 days
Days inventory outstanding 49 days 10 days
100th		 136 days
Days payables outstanding 503 days 21 days
100th		 59 days
Cash conversion cycle (days) −402 days 22 days
0th		 70 days
Capex / revenue 5.4% 2.5%
77th		 2.6%
Capex / depreciation 1.52 0.83
84th		 0.55
Operating expense ratio 79.7% 16.0%
100th		 56.5%

Cash flow & earnings quality

MeasureUHSIndustry medianIndustry percentileSector median
Operating cash flow / net income 1.18 1.64
9th		 1.61
FCF / net income 0.54 1.33
4th		 1.36
FCF / operating cash flow 45.9% 75.3%
18th		 81.2%
Capex / operating cash flow 54.1% 24.7%
82nd		 18.8%
Accruals ratio -1.8% -6.3%
94th		 -5.4%
Sloan accruals ratio -6.0% -3.0%
28th		 -1.3%
Earnings quality score (0-1) 1.00 0.75
65th		 0.75

Dividends & buybacks

MeasureUHSIndustry medianIndustry percentileSector median
Dividend yield 0.4% 0.0%
81st		 0.0%
Dividend per share (TTM) $0.80 $0.00
88th		 $0.00
Payout ratio (dividends / net income) 3.2% 0.0%
59th		 0.0%
Dividends / FCF 6.0% 0.0%
69th		 0.0%
Dividend growth (YoY) 1.9% 3.8%
42nd		 4.5%
Buyback yield 9.8% 0.8%
97th		 0.0%
Shareholder yield (dividends + buybacks) 10.3% 1.2%
94th		 0.0%
Share count change (YoY) -7.8% 0.6%
19th		 2.0%
Buybacks, last 5 years $3.5B $60.6M
91st		 $0

Scores & forensic checks

MeasureUHSIndustry medianIndustry percentileSector median
IS score 61 57
59th		 46
IS profitability 60 32
91st		 22
IS growth 63 65
47th		 60
IS value 88 48
100th		 39
IS momentum 86 85
53rd		 67
IS risk (safety) 65 65
44th		 80
IS quality 79 61
84th		 49
IS balance sheet 61 50
66th		 55
IS earnings quality 79 72
81st		 56
IS cash flow 40 59
28th		 41
Piotroski F-score (0-9) 8 6
78th		 5
Altman Z-score 3.0 2.7
53rd		 3.2
Beneish M-score −2.37 −2.63
69th		 −2.62
Ohlson O-score −8.39 −7.12
22nd		 −7.16
IS credit score 71 60
59th		 62

Per share

MeasureUHSIndustry medianIndustry percentileSector median
EPS, diluted (TTM) $25.46 $1.22
91st		 −$0.03
Book value per share $125.35 $9.99
100th		 $7.10
Tangible book per share $61.59 $0.91
97th		 $1.91
Revenue per share $302.21 $36.86
94th		 $9.38
FCF per share $13.79 $2.23
84th		 $0.46
Operating cash flow per share $30.03 $2.62
88th		 $0.93
Cash per share $2.32 $1.87
53rd		 $3.51

Size (TTM)

MeasureUHSIndustry medianIndustry percentileSector median
Market cap $10.9B $2.4B
88th		 $2.4B
Revenue $18.1B $2.6B
91st		 $770.2M
EBITDA $2.8B $303.8M
91st		 $56.1M
Net income $1.5B $104.9M
94th		 −$3.3M
Free cash flow $826.7M $165.8M
91st		 $41.2M
Total assets $15.9B $2.4B
91st		 $1.3B
Shareholders' equity $7.5B $741.3M
100th		 $568.4M
Employees 101,500 15,278
97th		 1,086

Insider transactions, last 6 months

Form 4 · most recent 12
DateInsiderTypeSharesPriceValueOwned after
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 9,418——0
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 13,963——1,810,129
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 9,418——1,819,547
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 9,418——1,828,965
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 14,163——10,132
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 14,163——1,843,128
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 14,163——1,857,291
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 14,163——1,871,454
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 50,990——1,820,464
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 50,990——50,990
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 25,495——1,794,969
2026-05-27Miller Alan B
Director, 10 percent owner, Executive Ch
 Other 25,495——25,495

Shares acquired vs disposed, by month

acquired disposed · all Form 4 types
MarMay

By transaction type, 6 months

TypeDirectionFilingsSharesValue
Award / grantAcquired56,085—
OtherAcquired8151,773—
OtherDisposed5125,561—
Awards, option exercises and tax withholding are compensation mechanics; open-market buys and sales are the discretionary ones.

Form 144 notices

12 months: 4 notices · 5,456 shares · $1.2M
FiledFilerShares proposedEst. proceeds
2026-03-13Elliot Sussman356$68,841
2026-03-11Elliot Sussman318$59,258
2025-11-12Warren Nimetz3,817$852,343
2025-10-29Elliot Sussman965$217,799
A Form 144 is notice of a proposed sale, not a confirmed one.

Congress trades

12 months: House 2 trades (2 purchases) · Senate 1 (1 purchases)
TradedMemberChamberTypeAmountDisclosed
2026-03-27Alan ArmstrongSenatePurchase$1,001 - $15,0002026-07-20
2025-10-23Julia LetlowHousePurchase$1,001 - $15,0002026-01-13
2025-10-22Julia LetlowHousePurchase$1,001 - $15,0002026-01-13
2023-03-24Ro KhannaHouseSale$1,001 - $15,0002023-04-07
2023-03-14Ro KhannaHouseSale$1,001 - $15,0002023-04-07
STOCK Act disclosures, in ranges, filed up to 45 days after the trade.

Largest 13F holders

Quarter to 2026-06-30, the latest most managers have filed
ManagerSharesValue% of shares out
First Eagle Investment Management, LLC4,554,670$677.2M7.73%
BlackRock, Inc.4,059,826$603.7M6.89%
VANGUARD CAPITAL MANAGEMENT LLC3,392,199$504.4M5.76%
VANGUARD PORTFOLIO MANAGEMENT LLC2,452,177$364.6M4.16%
DIMENSIONAL FUND ADVISORS LP2,210,595$328.7M3.75%
STATE STREET CORP2,102,613$312.6M3.57%
GEODE CAPITAL MANAGEMENT, LLC1,974,065$293.2M3.35%
PZENA INVESTMENT MANAGEMENT LLC1,969,327$292.8M3.34%
Invesco Ltd.1,951,147$290.1M3.31%
FMR LLC1,416,755$210.7M2.40%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1,415,848$210.5M2.40%
LOS ANGELES CAPITAL MANAGEMENT LLC1,068,124$158.8M1.81%
AMERICAN CENTURY COMPANIES INC944,592$140.5M1.60%
LSV ASSET MANAGEMENT942,682$140.2M1.60%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/906,103$135.5M1.54%

Institutional ownership by quarter

2023-092026-0688.6%
% of shares held by 13F filers
2023-092026-06599
Number of 13F filers holding

Holder changes by quarter

QuarterHoldersOwnershipNewIncreasedReducedClosed
2026-06-3059988.6%70218244123
2026-03-3165586.5%7325723696
2025-12-3169185.5%12724822057
2025-09-3063387.5%9822224380
2025-06-3062589.7%8524523068
2025-03-3161891.8%9025718865
2024-12-3160490.5%100203225107
2024-09-3062089.5%13922817446
2024-06-3053291.1%7920417239
2024-03-3149893.6%8716016846
2023-12-3146397.1%7412320144
2023-09-3044197.1%6414416278

Schedule 13D / 13G filers

FiledFormFiler% of classShares
2026-10-08SCHEDULE 13GDimensional Fund Advisors LP5.2%2,679,916
2026-08-06SCHEDULE 13G/AFIRST EAGLE GLOBAL FUND5.8%3,108,317
2026-04-30SCHEDULE 13GVanguard Capital Management7.3%3,922,926
2026-03-27SCHEDULE 13G/AThe Vanguard Group0.0%0
Required above 5% of a class; 13G is the passive form.

ETFs with the largest holding

ETFWeight in fundHolding value
VITSX0.01%$271.0M
VTSAX0.01%$271.0M
VSMPX0.01%$271.0M
VTI0.01%$271.0M
VFINX0.01%$236.4M
VOO0.01%$236.4M

Share structure

Shares outstanding58,936,513
Float48,791,371
Free float82.8%

Income statement

Fiscal years, USD
FY2021FY2022FY2023FY2024FY2025
Revenue$12.6B$13.4B$14.3B$15.8B$17.4B
Cost of revenue$1.4B$1.5B$1.5B$1.6B$1.7B
Gross profit$11.2B$11.9B$12.7B$14.2B$15.7B
R&D$0$0$0$0$0
SG&A$6.3B$6.9B$7.2B$7.7B$8.2B
Operating income$1.4B$1.0B$1.2B$1.7B$2.0B
EBITDA$1.9B$1.6B$1.7B$2.3B$2.7B
Pretax income$1.3B$866.3M$940.4M$1.5B$2.0B
Income tax$305.7M$209.3M$221.1M$334.8M$461.0M
Net income$991.6M$675.6M$717.8M$1.1B$1.5B
EPS, diluted$11.82$9.14$10.23$16.82$23.10
Diluted shares83.7M73.8M70.1M67.9M64.5M

Balance sheet

FY2021FY2022FY2023FY2024FY2025
Cash & short-term investments$115.3M$102.8M$119.4M$126.0M$137.8M
Receivables$1.7B$2.0B$2.2B$2.2B$2.6B
Inventory$206.8M$218.5M$217.0M$220.9M$232.1M
Total current assets$2.3B$2.5B$2.8B$2.8B$3.4B
PP&E, net$6.2B$6.4B$6.6B$7.0B$7.4B
Goodwill & intangibles$4.0B$3.9B$3.9B$4.0B$4.1B
Total assets$13.1B$13.5B$14.0B$14.5B$16.0B
Accounts payable$658.9M$636.6M$614.0M$632.0M$750.1M
Total current liabilities$2.0B$1.9B$2.0B$2.2B$3.2B
Long-term debt$4.1B$4.7B$4.8B$4.5B$4.3B
Total liabilities$6.9B$7.5B$7.8B$7.7B$8.5B
Shareholders' equity$6.2B$6.0B$6.2B$6.8B$7.4B

Cash flow statement

Outflows are negative
FY2021FY2022FY2023FY2024FY2025
Net income$987.6M$657.0M$717.5M$1.2B$1.5B
Depreciation & amortization$533.2M$581.9M$568.0M$584.8M$618.7M
Stock-based compensation$73.7M$85.4M$87.7M$99.3M$95.7M
Change in working capital−$736.9M−$244.3M$17.1M$418.8M−$275.9M
Operating cash flow$883.7M$996.0M$1.3B$2.1B$1.9B
Capital expenditure−$855.7M−$734.0M−$743.1M−$943.8M−$1.0B
Free cash flow$28.0M$262.0M$524.7M$1.1B$849.2M
Investing cash flow−$914.5M−$647.3M−$763.3M−$911.1M−$1.1B
Net debt issued / repaid$217.1M$616.0M$99.6M−$429.8M$241.7M
Buybacks−$1.2B−$832.9M−$547.4M−$670.8M−$968.0M
Dividends paid−$65.9M−$58.4M−$55.5M−$53.3M−$51.3M

Ratio history

Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end
FY2021FY2022FY2023FY2024FY2025
Gross margin88.7%89.0%89.3%90.0%90.4%
Operating margin10.8%7.5%8.2%10.6%11.5%
Net margin7.8%5.0%5.0%7.2%8.6%
FCF margin0.2%2.0%3.7%7.1%4.8%
ROE16.0%11.2%11.9%17.8%21.4%
ROIC9.9%6.9%7.9%11.4%12.1%
ROA7.4%5.1%5.2%8.0%9.8%
Debt / equity0.750.890.870.740.76
Interest coverage16.7x7.8x5.5x9.0x13.6x
Current ratio1.141.331.401.271.05
Revenue growth+9.4%+6.0%+6.6%+10.8%+9.7%
EPS growth+13.0%−24.3%+11.4%+62.6%+35.6%
P/E at year end10.2x14.8x14.4x10.5x9.4x
EV / EBITDA at year end7.6x9.6x9.1x7.4x7.1x
FCF yield at year end0.28%2.63%5.06%9.37%5.91%
Dividend payout6.7%8.7%7.7%4.7%3.4%

Revenue by segment

FY2021FY2022FY2023FY2024FY2025
Acute Care Hospital Services$7.1B$7.6B$8.1B$8.9B$9.9B
Behavioral Health Services$5.5B$5.7B$6.2B$6.9B$7.4B
All Other Segments$30.2M$22.9M$9.7M——

Street estimates by fiscal year

Next report 2026-10-27 · consensus EPS $5.20 · these are analysts' numbers, not ours
Fiscal yearRevenue (mean)Revenue rangeEPS (mean)EPS rangeAnalystsP/E on mean EPS
2026$18.6B$18.5B – $18.9B$22.56$22.10 – $23.18128.2x
2027$19.5B$19.2B – $20.0B$23.93$22.11 – $25.81127.7x
2028$20.4B$19.3B – $21.1B$26.22$24.03 – $28.0097.1x

Reported vs expected, every quarter on file

ReportedEPS expectedEPS actualEPS surpriseRevenue expectedRevenue actualRevenue surprise
2026-07-27$5.94$5.98+0.7%$4.6B$4.6B+1.3%
2026-04-27$5.29$5.62+6.2%$4.4B$4.5B+2.5%
2026-02-25$5.92$5.88−0.7%$4.5B$4.5B−0.4%
2025-10-27$4.66$5.69+22.1%$4.5B$4.5B−0.2%
2025-07-28$4.92$5.35+8.7%$4.2B$4.3B+1.1%
2025-04-28$4.35$4.84+11.3%$4.2B$4.1B−1.3%
2025-02-26$4.21$4.92+16.9%$4.0B$4.1B+2.7%
2024-10-24$3.65$3.71+1.6%$4.0B$4.0B−1.2%
2024-07-24$3.28$4.31+31.4%$3.9B$3.9B+1.1%
2024-04-24$3.15$3.70+17.5%$3.8B$3.8B+1.8%
2024-02-27$2.88$3.13+8.7%$3.7B$3.7B+1.1%
2023-10-25$2.36$2.55+8.1%$3.7B$3.6B−2.8%
2023-07-25$2.43$2.53+4.1%$3.5B$3.5B+0.5%
2023-04-25$2.19$2.34+6.8%$3.5B$3.5B−1.0%
2023-02-27$2.96$3.02+2.0%$3.4B$3.4B+1.5%
2022-10-25$2.43$2.54+4.5%$3.3B$3.3B+1.6%
2022-07-25$2.35$2.20−6.4%$3.3B$3.3B+1.5%
2022-04-25$2.46$2.15−12.6%$3.2B$3.3B+1.5%
2022-02-24$2.87$2.95+2.8%$3.1B$3.3B+4.5%
2021-10-25$2.75$2.67−2.9%$3.1B$3.2B+2.2%
2021-07-26$2.70$3.76+39.3%$3.1B$3.2B+3.6%
2021-04-26$2.27$2.44+7.5%$3.0B$3.0B+1.6%
2021-02-25$2.78$3.59+29.1%$3.0B$3.1B+3.3%
2020-10-29$1.94$2.88+48.5%$1.9B$2.9B+50.0%

Off-exchange (dark pool) volume, weekly

FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)
0.206-150.206-220.206-290.207-060.207-130.207-200.407-270.208-030.208-100.208-170.108-240.208-31
Week ofNotionalSharesTrades
2026-08-31$161.5M950,76638,402
2026-08-24$145.5M830,91632,600
2026-08-17$171.5M985,52434,376
2026-08-10$157.7M920,87334,268
2026-08-03$167.4M983,22136,411
2026-07-27$440.4M2,683,46357,968

Short-sale share of off-exchange volume

daily 20-day average
07-2310-1562.8%
DateShort shareShort volumeTotal volume
2026-10-1562.8%100,879160,555
2026-10-1469.0%171,952249,135
2026-10-1361.7%132,691215,022
2026-10-1265.7%109,743167,150
2026-10-0972.1%92,465128,184
2026-10-0876.9%107,336139,615
2026-10-0772.8%137,929189,435
2026-10-0676.3%104,088136,445
2026-10-0557.2%101,607177,728
2026-10-0279.9%149,879187,617
A daily flow measure from FINRA, not short interest.

Seasonality

Average return by calendar month
+0.6Jan+1.2Feb+1.4Mar+4.4Apr+3.2May-0.8Jun+2.1Jul-0.5Aug+0.4Sep-1.6Oct+3.2Nov+1.3Dec
MonthAvg returnUp yearsYears
Jan+0.6%50%20
Feb+1.2%60%20
Mar+1.4%67%21
Apr+4.4%65%20
May+3.2%80%20
Jun−0.8%30%20
Jul+2.1%55%20
Aug−0.5%45%20
Sep+0.4%50%20
Oct−1.6%35%20
Nov+3.2%75%20
Dec+1.3%65%20
History, not a forecast.

Indicators

as of 2026-10-16
RSI 1463.5
MFI44.4
ADX17.5
Stochastic %K / %D80.8 / 72.2
Williams %R-31.5
CCI165
TSI / signal17.7 / 11.3
Chaikin money flow-0.26
ATR$4.82
Bollinger width8.4%
Volume vs 20-day avg0.59x
SupertrendUp

Moving averages and bands

level (price vs level)
SMA 20$178.33 (+3.8%)
SMA 50$175.32 (+5.6%)
SMA 200$178.44 (+3.7%)
EMA 21$178.77 (+3.5%)
EMA 50$174.55 (+6.0%)
EMA 200$176.68 (+4.8%)
Bollinger upper$185.82 (−0.4%)
Bollinger lower$170.83 (+8.4%)
Parabolic SAR$175.21 (+5.6%)
Open the live chart, 110+ indicators

About Universal Health Services, Inc.

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its business operations are strategically bifurcated into two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The hospitals under its management provide a comprehensive spectrum of medical provisions, encompassing general and specialty surgical interventions, internal medicine, obstetrics, urgent and emergency department services, diagnostic imaging (radiology), cancer therapy (oncology), advanced diagnostic procedures, cardiac care, pediatric medicine, pharmaceutical services, and mental health support. As of a reported date of February 24, 2022, the company's significant presence included the ownership or operation of 363 inpatient facilities, complemented by 40 outpatient and other specialized sites. These facilities are distributed across 39 U.S. states, the District of Columbia, the United Kingdom, and Puerto Rico. Beyond direct patient care, UHS also extends into commercial health insurance provision and offers a variety of crucial management support functions. These include centralized procurement, information technology infrastructure, financial oversight and control mechanisms, strategic facilities planning, physician talent acquisition, administrative staff management, marketing initiatives, and public relations efforts. Universal Health Services, Inc. was established in 1978 and maintains its principal executive offices in King of Prussia, Pennsylvania.

https://uhs.com

Key executives

NameTitlePayBorn
Marc D. MillerChief Executive Officer, President & Director$6.1M1971
Alan MillerFounder & Executive Chairman of the Board$3.0M1938
Steve G. FiltonExecutive Vice President, Chief Financial Officer & Secretary$2.6M1958
Edward H. SimExecutive Vice President & President of Acute Care Division$2.4M1972
Darren LehrichVice President of Investor Relations—1972
Jim ClarkSenior Vice President of Finance - Acute Care Division——
Maria ZangardiSenior Vice President of Human Resources——
Matthew David KleinSenior Vice President & General Counsel——

Executive pay, latest proxy

ExecutiveYearSalaryStock awardsIncentiveTotal
Marc D. Miller, Chief Executive Officer and President2025$1.4M$10.0M$4.3M$16.1M
Alan B. Miller, Executive Chairman2025$1.1M$5.1M$0$8.1M
Steve G. Filton, Executive Vice President and Chief Financial Officer2025$853,299$2.5M$1.7M$5.1M
Edward H. Sim, Executive Vice President and President, Acute Care (6.)2025$802,024$2.3M$1.6M$4.8M
Matthew J. Peterson, Executive Vice President and President, Behavioral Health2025$719,971$2.0M$1.4M$4.2M

Employees

56k201858k201989k202089k202194k202297k202399k2024102k2025

Dividends

Ex-dateAmountPaid
2026-09-01$0.22026-09-15
2026-06-08$0.22026-06-18
2026-03-02$0.22026-03-16
2025-12-01$0.22025-12-15
2025-09-02$0.22025-09-16
2025-06-02$0.22025-06-16
2025-03-03$0.22025-03-17
2024-12-03$0.22024-12-17

Moat model

Narrow · Intangible Assets · 2026-06-30
Cost advantage57
Intangibles79
Switching costs67
Network effect67
Efficient scale53
Our component scores (0-100) and overall 65.9; a model of the business, not a call on the stock.
InsiderStreet reports findings from filings and market data. Nothing on this page is a recommendation to buy or sell.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms